# SARSCoV2 (COVID-19) Convalescent Plasma (CP) Expanded Access Protocol (EAP)

> **NCT04374370** · — · NO_LONGER_AVAILABLE · sponsor: **AdventHealth**

## Conditions studied

- COVID
- SARSCoV2 Convalescent Plasma

## Interventions

- **BIOLOGICAL:** SARSCoV2 Convalescent Plasma

## Key facts

- **NCT ID:** NCT04374370
- **Lead sponsor:** AdventHealth
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2021-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04374370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04374370, "SARSCoV2 (COVID-19) Convalescent Plasma (CP) Expanded Access Protocol (EAP)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04374370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*